April 11, 2017 by Chain Drug Review
Appriss Health, Bill Shinton, Brian Calley, Kroger, Kroger pharmacies, Michigan Automated Prescription System, Michigan's prescription drug monitoring program, NARxCHECK, PMP AWARxE, prescription drug abuse, Rick Snyder, Rob Cohen
Leading Headlines, Pharmacy, Retail News, Technology
LOUISVILLE, Ky. — Kroger pharmacies in Michigan have integrated Michigan Automated Prescription System (MAPS) data and advanced analytics into their workflow to better track prescription drug abuse. Kroger’s integration into MAPS was facilitated by Appriss Health, a technology partner for Michigan’s prescription drug monitoring program (PDMP). Appriss Health said Tuesday that Kroger can now directly
December 9, 2016 by CDR Blog and Chain Drug Review
Fred's, Kroger, Rite Aid, Walgreens, Walgreens Boots Alliance, Walgreens-Rite Aid merger
CDR Blog
Chain drug industry watchers have kept hearing and reading the scuttlebutt about the closing of the Walgreens-Rite Aid merger deal. But a report late Friday afternoon suggested that approval of the $17.2 billion transaction may be imminent. Investor website Seeking Alpha reported that Walgreens Boots Alliance (WBA) is slated to have a package of store
November 21, 2016 by Mark Baumgartner and Chain Drug Review
2016 PoweRanking, Daniel Raynak, Kantar PoweRanking, Kantar Retail, Kroger, Walmart
2016, Issue 11-21-2016, Issues, News
NORWALK, Conn. — Walmart and Kroger Co. finished in a virtual tie as the top retailer in the 2016 PoweRanking determined by consulting firm Kantar Retail LLC. PepsiCo and Coca-Cola Co. were at the top of the rankings of manufacturers in this year’s survey. Walmart has been atop the retailer rankings for more than a
November 7, 2016 by Geoff Walden and Chain Drug Review
CVS Health, Deutsche Bank Securities, Federal Trade Commission, George Hill, Kroger, Rite Aid, Stefano Pessina, Walgreens Boots Alliance, Walmart, WBA-Rite Aid merger
2016, Issue 11-07-2016, Issues, News
DEERFIELD, Ill. — Walgreens Boots Alliance Inc. (WBA) and Rite Aid Corp. have extended the time frame for completing their planned $17.2 billion merger. The companies have pushed back the end date for the deal by three months to January 27, and they expect the transaction to close early next year. Both companies had the
October 24, 2016 by Geoff Walden and Chain Drug Review
Bartell Drugs, chain drug industry, chain pharmacy industry, CVS Pharmacy, Giant Eagle, H-E-B, Hy-Vee, Kroger, Publix, regional drug chains, Rite Aid, U.S. prescription market, Walgreens Boots Alliance, Walmart
2016, Business, Featured Articles, Issue 10-24-2016, Issues, Leading Headlines, News, Retail News
NEW YORK — Competition remains fierce in the chain pharmacy industry, albeit with a decreasing number of players. If the pending acquisition of Rite Aid Corp. by Walgreens Boots Alliance Inc. goes through, the field will diminish dramatically, especially in major metropolitan areas. Depending on the number of stores WBA divests to meet antitrust requirements,
October 19, 2016 by CDR Blog and Chain Drug Review
FTC approval, Kroger, Walgreens Boots Alliance, Walgreens-Rite Aid merger
CDR Blog
Apparently, Kroger might not become the enabler for Federal Trade Commission approval of the Walgreens-Rite Aid merger. The New York Post reported late Tuesday that Kroger may be taking a pass on buying Walgreens and/or Rite Aid stores that would need to be divested by Walgreens Boots Alliance to gain FTC clearance for its $17
October 10, 2016 by Geoff Walden and Chain Drug Review
CVS, Federal Trade Commission, FTC, Kroger, Rite Aid, Stefano Pessina, Walgreens, Walgreens Boots Alliance, WBA, WBA-Rite Aid
2016, Issue 10-10-2016, Issues, News
NEW YORK — Speculation continues to percolate about snags holding up Walgreens Boots Alliance Inc.’s (WBA’s) acquisition of Rite Aid Corp. Last last month the New York Post reported that private equity firms were uninterested in purchasing 650 stores that WBA must divest to satisfy antitrust requirements. Investors found the stores to be subpar and
September 29, 2016 by CDR Blog and Chain Drug Review
chain drug industry, CVS, Federal Trade Commission, Kroger, Rite Aid, Scott Mushkin, Walgreens Boots Alliance, Walmart, WBA, Wolfe Research
CDR Blog
It looks like one divestment possibility for Walgreens Boots Alliance isn’t panning out as it works with the Federal Trade Commission to gain antitrust clearance for its acquisition of Rite Aid. The New York Post reported this week that WBA hasn’t been able to sway private equity firms to buy a chunk of Walgreens and/or
September 26, 2016 by Geoff Walden and Chain Drug Review
Federal Trade Commission, Kroger, Rite Aid, Rite Aid acquisition, Walgreens Boots Alliance
2016, Issue 09-26-2016, Issues, News
DEERFIELD, Ill. — Walgreens Boots Alliance Inc. (WBA) has upped the number of stores that it expects to divest to gain government clearance for its $17.2 billion purchase of Rite Aid Corp. WBA said this month that between 500 and 1,000 Walgreens and/or Rite Aid stores will probably have to be divested to win Federal
September 12, 2016 by John Schultz and Chain Drug Review
Albertsons, CVS Pharmacy, flu shots, flu vaccines, Jocelyn Konrad, Kroger, Mark Panzer, Meijer, MinuteClinic, Papatya Tankut, Philecia Avery, Richard Ashworth, Rite Aid, The Little Clinic, Tim Lesneski, Walgreens, Walgreens Healthcare Clinic
2016, Issue 09-12-2016, Issues, News
NEW YORK — The Centers for Disease Control and Prevention recommends an annual flu shot for everyone over the age of six months, and retail pharmacies across the nation are spreading the word of their ability to provide such health services. Walgreens is now offering flu shots at all of its pharmacies (including Duane Reade
September 7, 2016 by CDR Blog and Chain Drug Review
Albertsons, Kroger, Rite Aid, Sareway Haggen, Walgreens, Walgreens Boots Alliance, WBA
CDR Blog, Leading Headlines
The suspense (or impatience?) continues to build in the investor and retailing communities as Walgreens Boots Alliance’s $17.2 billion deal to buy Rite Aid remains under review by the Federal Trade Commission. Lately, speculation has centered on Kroger as a potential buyer of stores that would be divested by WBA for the FTC to sign
August 17, 2016 by Chain Drug Review
Bartell Drugs, Billy Chow, Chuck Paulsen, Kroger, NACDS, National Association of Chain Drug Stores, pharmacy-administered vaccinations, QFC Pharmacy, QFC Stores, Sean Sullivan, Steve Anderson, University of Washington School of Pharmacy, Washington State Health Care Authority
Leading Headlines, Pharmacy, Retail News
SEATTLE — Bartell Drugs and QFC Pharmacy, the pharmacy arm of Kroger Co.’s QFC Stores supermarket chain, have launched projects to test models for pharmacy-provided immunizations. As part of a National Association of Chain Drug Stores initiative announced in late July, Bartell and QFC are partnering with the University of Washington School of Pharmacy (UWSOP)
August 15, 2016 by Chain Drug Review
Colleen Lindholz, Feeding America, flu shot, Kroger, Philecia Avery, The Little Clinic
Leading Headlines, Pharmacy, Retail News
CINCINNATI — Kroger Co. is supporting Feeding America food banks through a new health and wellness program with its in-store pharmacies and The Little Clinic retail health clinics. Kroger said Monday that through April 1, 2017, it will donate one meal via the Feeding America food bank network for each flu shot administered at its
August 6, 2016 by Greg Jacobson and Chain Drug Review
Axium Pharmacy Holdings, Dom Meffe, Kroger, Mark Montgomery, Modern HC Holdings, ModernHEALTH, specialty pharmacy
2016, Issue 08-08-2016, Issues, News
CINCINNATI — Axium Pharmacy Holdings Inc., a unit of Kroger Co., has agreed to acquire Modern HC Holdings Inc. (ModernHEALTH), a specialty pharmacy operator, to create a combined specialty pharmacy organization. Terms of the transaction, which is subject to regulatory approval, were not disclosed. The new entity will operate as a wholly owned subsidiary of